The improved neuroplasticity resulting from GLP-1RA therapy appears to be mediated by GLP-1 receptors in the hippocampus
Riboflavin transporter SLC52A1, a target of p53, suppresses cellular senescence by activating mitochondrial complex II
The dermis is the skin's middle layer, which contains collagen
Stacking IGF-1 LR3 with SARMs When stacked with Selective Androgen Receptor Modulators (SARMs) , IGF-1 LR3 can enhance lean muscle gains, accelerate recovery, and optimize nutrient partitioning all without the harsh side effects often associated with anabolic steroids
The FDA is initiating a formal review process, not granting approval
This two-way influence creates a dynamic loop where diet, microbiome, and behaviour all play a role in modulating GLP-1 secretion